Johnson L Z, Martinez I, Fernández M C, Davis C P, Kasinath B S
Departments of Medicine and Surgery, South Texas Poison Center, San Antonio, TX, USA.
Am J Kidney Dis. 1999 Apr;33(4):786-9. doi: 10.1016/s0272-6386(99)70235-0.
A 43-year-old woman took a large amount of depakote (divalproex, a slow-release form of valproate), became comatose, and developed severe hypotension refractory to fluid resuscitation and high-dose vasopressors. The serum valproic acid (VPA) concentration on admission was 1,380 microgram/mL (therapeutic range, 50 to 100 microgram/mL). She also had metabolic acidosis, thrombocytopenia, and normal renal and liver functions. Hemodialysis was initiated 4 hours after presentation. After 6 hours of hemodialysis with a high-flux dialyzer, her serum VPA concentration decreased from 940 microgram/mL to 164 microgram/mL, coincident with improvement in clinical status. The half-life of VPA was reduced to 2.4 hours with hemodialysis, whereas it was 7.2 hours before the procedure. Hemodialysis could be a valuable therapeutic intervention in VPA toxicity.
一名43岁女性服用了大量德巴金(丙戊酸镁,丙戊酸盐的缓释剂型),陷入昏迷,并出现严重低血压,对液体复苏和大剂量血管加压药治疗无效。入院时血清丙戊酸(VPA)浓度为1380微克/毫升(治疗范围为50至100微克/毫升)。她还存在代谢性酸中毒、血小板减少,肾功能和肝功能正常。就诊4小时后开始进行血液透析。使用高通量透析器进行6小时血液透析后,她的血清VPA浓度从940微克/毫升降至164微克/毫升,同时临床状况有所改善。血液透析使VPA的半衰期缩短至2.4小时,而在透析前为7.2小时。血液透析可能是治疗VPA中毒的一种有价值的治疗干预措施。